The stock issue is bizarre. I struggle to believe Boots didn't anticipate strong demand for PCR tests. Dare I say that sales are even stronger than the strong sales they expected? Can't wait for some June/July/Aug passenger number comparisons.
This stock issue is starting to go from a positive sign to getting a little bit frustrating. If I understand previous comments, Boots saying not their fault, Wallbrooks saying not MHC fault.
Instead of playing the blame game it would be nice if all parties just focused on fixing it.
Moore, you can simply Google this "MyHealthChecked investor presentation - YouTube" and you will find what you are looking for. Google is your friend when it comes to finding out this information :)
I personally can't see us hitting sub-3p again personally unless other drastic news comes along or the turmoil in the markets ramps up even a little bit (both of which are possible).
My guess (and it is a guess) is PCR tests will stay at least for the summer period which is the busiest passenger travel period in the year. Most likely until at least the end of the year, and possibly even for the full Winter 2021/2 period.
I agree, it would be nice for MHC to tell us what they intend to do with their "significant increase in revenues". But there's a lot of things it would be nice for MHC to tell us however they don't seem too keen on doing that.
Sorry, I should have clarified - I meant mainly from a consumers perspective twitter is important. Especially for retail products. It's not the be-all-and-end-all of course but it does play a big part.
Just as an aside, although it's a totally different industry but relevant to your EUA example - I know KOD (A lithium & gold mining firm) has done particularly well which I believe has been helped by its active Twitter presence. It's attracted a lot of retail investors by just showing off how hard they are working, stuff that is normally left behind the scenes.
If they want to get ahead with the sales of their DNA testing products which are not going to be as easy as their PCR tests then they need to start building a brand, social media & high street presence today, in fact yesterday not tomorrow.
I agree with Atlantic. I understand they are busy with Covid tests but why can't they even sustain a twitter account. If I was looking into buying a healthcare test product and checked their twitter account and seen they hadn't tweeted since January I would start to question how reliable this company is, are they even still operating? It's simple things like this which working on now will benefit us in the future.
It's not going to be a good look if the next tweet is the day they launch their products with zero hype beforehand imo. As much as I believe in MHC I'm not ignorant to how consumers & more importantly, other investors will react to the actions this company is taking.
Some positive news here:
"Fully vaccinated travellers from the EU and the US will be able to avoid quarantining when they arrive in England from next Monday, the government has confirmed.
Transport Secretary Grant Shapps has also announced the resumption of international cruises.
The change regarding US and EU arrivals come into force from 4am on 2 August."
A negative PCR test is STILL required. Next step is for the US to open their borders, however they have said they won't even be opening up to Mexico/Canada until at least August 21st.
I personally expect this to continue to go down soon if there isn't news in the very near future, to be honest - it does seem to be in a state of hype at the moment, something will be needed to sustain it. Even though I fully believe there is good news coming, timing is key.
I suppose the question is, when does it end. This has been going on since May, if not before..
I can tell you what they’re definitely not spending it on.
Marketing &PR!!!
I imagine they're still listed as Boots still have unsold tests in their inventory and are just waiting for them to clear. I imagine once it goes out of stock it will disappear from the website.
It's a shame to see the recent price action with the SP and the lack of PR from MHC throughout the past couple of months has gone from frustrating to flat out annoying imo. If they're still wanting to release their retail products this year then I would've thought they would be working on their social media presence a bit. We know they have more than enough cash to hire someone to manage this for them now, really wish they would.
Nice to see some positivity coming back into the discussion surrounding MHC, not just on LSE but hearing good things about MHC at many places at the moment.
We should be expecting a "Phase 3 Launch" on Wednesday which I am going to assume is the non-covid DNA testing kits which have been listed as "Coming Soon" for a couple of months now. In their investor presentation, MHC say these will be "priced attractively - £20 - £30 for core single range".
I have a strong belief in the lactose/coeliac tests and I think these will be strong sellers. I've said it before but I can't really see a strong market for the other tests unless there is some kind of attractive 2 for 1 deal going on. But nonetheless I still believe in the strong PCR tests we will receive and hopefully the DNA test portfolio continues to grow with more attractive products!
Yeah Bakky, they had a bit of a range when I went in today. Here is a photo of the full COVID-19 testing shelf: https://i.imgur.com/kjDYOCc.jpg
Went into a Boots store today to check up on our magnificent product. Out of stock, as were the much more expensive Crohnomics offering on the shelf next to them.
Came home and checked the online stock list near me, the first page has 18 results. 9 out of 18 closest stores are Out of Stock. They were all in stock the past few months.
Tests selling extremely well it looks like. 52 people currently looking at the product page at midday on a Friday :-)
It seems that the potential here is not just potential but a foregone conclusion. And a conclusion which I am happy to put money on. However, the market still is really skittish about this share and it's quite unfortunate. I assume we've just been tarnished with the same brush as the rest of the COVID-stocks in 2021, nobody wants to touch them because the market feels like COVID support could be pulled at any time - but that doesn't really apply to MHC, we know PCR is here to stay.
I'm hoping the last two weeks of July things start to perk up for MHC assuming the "Phase 3 Product Launch" still goes ahead. Disappointing few months here despite consistent fantastic news just let down by poor PR and bad timing.
I hope the market starts to catch up soon...
I would love an update by Mid-August. Don't think we'll get one but would be so great to get.
If their investor presentation is correct and timelines haven’t changed their Phase 3 product launch is pencilled in for Friday (9th July)..
£3m revenue in 2 months.. and let's not forget this was 2 months where for the most part you couldn't travel anywhere without significant hassle or at all.
Bring on the holiday season, bring on quarantine scrapping for amber-list countries and MHC will be laughing.
not necessarily requiring a RNS* ... not PCR
I agree that this has the potential to get to 20p but I still fear we are being let down massively by "PR" or "Comms". I've been cutting them some slack as I have assumed they have been full steam on PCR but they are paying Wallbrooke PR to do this for them and it's just pitiful.
And after the horrendous June, we saw I feel like it's time to be a bit more vocal about their horrendous communications. Not even a single tweet since January 20th, bear in mind this company is a consumer healthcare diagnostics product they will need to find a way to appeal to customers just like any other consumer product.
This easyJet deal should've been all over MHC's socials today, not necessarily requiring a PCR but at least some positivity from the company may instil it in potential investors too.